QCM
DFTX

Quantinno Capital Management’s Definium Therapeutics DFTX Stock Holding History

Quantinno Capital Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$755K Buy
39,958
+634
+2% +$10.8K ﹤0.01% 2400
2025
Q4 		$527K Buy
39,324
+3,582
+10% +$44.3K ﹤0.01% 2374
2025
Q3 		$421K Buy
35,742
+18,588
+108% +$173K ﹤0.01% 2172
2025
Q2 		$111K Buy
+17,154
New +$113K ﹤0.01% 2492

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quantinno Capital Management's DFTX Position: Q1 2026 in Review

Quantinno Capital Management increased its Definium Therapeutics (DFTX) stake by 1.6% in Q1 2026, buying an estimated $10.8K and bringing the position to 39,958 shares worth $755K. The position accounts for ﹤0.01% of the portfolio, ranked #2400.

Quantinno Capital Management first reported a position in DFTX in Q2 2025 and has held it in 4 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Quantinno Capital Management held 39,958 shares of Definium Therapeutics worth $755K as of Q1 2026.
  • Quantinno Capital Management bought 634 Definium Therapeutics shares in Q1 2026, an estimated $10.8K.
  • Definium Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2400 holding.
  • Quantinno Capital Management first reported a position in Definium Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.